Aging is a strong risk indicator for cancer; the aging process itself is accompanied by metabolic decline, such as reduced insulin sensitivity and impaired glucose tolerance, both of which directly influence eGDR levels [29]. This evidence concerns the gene INS and Impaired glucose tolerance.